Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
19.89
+1.97 (10.99%)
At close: Jan 22, 2026, 4:00 PM EST
19.93
+0.04 (0.20%)
After-hours: Jan 22, 2026, 5:18 PM EST
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.36 billion as of January 22, 2026. Its market cap has increased by 120.68% in one year.
Market Cap
1.36B
Enterprise Value
1.33B
1-Year Change
120.68%
Ranking
Category
Stock Price
$19.89
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.36B, an increase of 955.82%. That is a compound annual growth rate of 9.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.22B | 6.04% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| uniQure | 1.41B |
| Trevi Therapeutics | 1.40B |
| Taysha Gene Therapies | 1.39B |
| AbCellera Biologics | 1.39B |
| Immatics | 1.36B |
| EyePoint | 1.35B |
| Sana Biotechnology | 1.33B |
| Rapport Therapeutics | 1.33B |